Alignment Healthcare (ALHC)
(Delayed Data from NSDQ)
$16.48 USD
-0.20 (-1.20%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $16.48 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ALHC 16.48 -0.20(-1.20%)
Will ALHC be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ALHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALHC
Are Medical Stocks Lagging Akebia Therapeutics (AKBA) This Year?
Clover Health Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?
ALHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Alignment Healthcare (ALHC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Alignment Healthcare (ALHC) Q2 Earnings and Revenues Surpass Estimates
Alignment Healthcare (ALHC) Upgraded to Buy: Here's What You Should Know
Other News for ALHC
ALHC forms NR7 on September 17
U.S. health insurers pledge continuing coverage of COVID shots ahead of ACIP meeting
Director Cashes In on Alignment Healthcare Stock Sale
GENERAL ATLANTIC, L.P. Reduces Stake in Alignment Healthcare Inc
20 Day Moving Average Support appears for ALHC after 1.35% move